SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-265826"
 

Sökning: id:"swepub:oai:DiVA.org:uu-265826" > Nitric oxide regula...

Nitric oxide regulation of migrating motor complex : randomized trial of N-G-monomethyl-L-arginine effects in relation to muscarinic and serotonergic receptor blockade

Halim, M. Abdul (författare)
Uppsala universitet,Gastroenterologi/hepatologi
Gillberg, Linda (författare)
Karolinska Institutet,Uppsala universitet,Institutionen för medicinska vetenskaper
Boghus, Sandy (författare)
Uppsala universitet,Institutionen för medicinska vetenskaper
visa fler...
Sundbom, Magnus (författare)
Uppsala universitet,Gastrointestinalkirurgi
Karlbom, Urban (författare)
Uppsala universitet,Kolorektalkirurgi
Webb, Dominic-Luc (författare)
Uppsala universitet,Gastroenterologi/hepatologi
Hellstrom, Per. M. (författare)
Uppsala universitet,Gastroenterologi/hepatologi
visa färre...
 (creator_code:org_t)
2015-07-30
2015
Engelska.
Ingår i: Acta Physiologica. - : Wiley. - 1748-1708 .- 1748-1716. ; 215:2, s. 105-118
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Aim: The migrating motor complex (MMC) propels contents through the gastrointestinal tract during fasting. Nitric oxide (NO) is an inhibitory neurotransmitter in the gastrointestinal tract. Little is known about how NO regulates the MMC. In this study, the aim was to examine nitrergic inhibition of the MMC in man using N-G-monomethyl-L-arginine (L-NMMA) in combination with muscarinic receptor antagonist atropine and 5-HT3 receptor antagonist ondansetron. Methods: Twenty-six healthy volunteers underwent antroduodenojejunal manometry for 8 h with saline or NO synthase (NOS) inhibitor L-NMMA randomly injected I.V. at 4 h with or without atropine or ondansetron. Plasma ghrelin, motilin and somatostatin were measured by ELISA. Intestinal muscle strip contractions were investigated for NO-dependent mechanisms using L-NMMA and tetrodotoxin. NOS expression was localized by immunohistochemistry. Results: L-NMMA elicited premature duodenojejunal phase III in all subjects but one, irrespective of atropine or ondansetron. L-NMMA shortened MMC cycle length, suppressed phase I and shifted motility towards phase II. Pre-treatment with atropine extended phase II, while ondansetron had no effect. L-NMMA did not change circulating ghrelin, motilin or somatostatin. Intestinal contractions were stimulated by L-NMMA, insensitive to tetrodotoxin. NOS immunoreactivity was detected in the myenteric plexus but not in smooth muscle cells. Conclusion: Nitric oxide suppresses phase III of MMC independent of muscarinic and 5-HT3 receptors as shown by nitrergic blockade, and acts through a neurocrine disinhibition step resulting in stimulated phase III of MMC independent of cholinergic or 5-HT3-ergic mechanisms. Furthermore, phase II of MMC is governed by inhibitory nitrergic and excitatory cholinergic, but not 5-HT3-ergic mechanisms.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Nyckelord

motility
myenteric plexus
N-G-monomethyl-L-arginine
nitric oxide
nitric oxide synthase

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy